Patients with functionally resectable pancreatic ductal adenocarcinoma (PDAC) according to NCCN criteria and Ca19-9 <500 U/ml (without relevant cholestasis)

1 total trials 1 recruiting

Filter these 1 trials by phase, country, sponsor and more.

Open in Search →

Showing 1–1 of 1 trials